Abstract:Nanomedicine application in cancer therapy is an urgency because of inability of current biological therapies for complete removal of tumor cells. The development of smart and novel nanoplatforms for treatment of cancer can provide new insight in tumor suppression. Hyaluronic acid is a biopolymer that can be employed for synthesis of smart nanostructures capable of selective targeting CD44-overexpressing tumor cells. The breast and lung cancers are among the most malignant and common tumors in both females and males that environmental factors, lifestyle and genomic alterations are among the risk factors for their pathogenesis and development. Since etiology of breast and lung tumors is not certain and multiple factors participate in their development, preventative measures have not been completely successful and studies have focused on developing new treatment strategies for them. The aim of current review is to provide a comprehensive discussion about application of hyaluronic acid-based nanostructures for treatment of breast and lung cancers. The main reason of using hyaluronic acid-based nanoparticles is their ability in targeting breast and lung cancers in a selective way due to upregulation of CD44 receptor on their surface. Moreover, nanocarriers developed from hyaluronic acid or functionalized with hyaluronic acid have high biocompatibility and their safety is appreciated. The drugs and genes used for treatment of breast and lung cancers lack specific accumulation at cancer site and their cytotoxicity is low, but hyaluronic acid-based nanostructures provide their targeted delivery to tumor site and by increasing internalization of drugs and genes in breast and lung tumor cells, they improve their therapeutic index. Furthermore, hyaluronic acid-based nanostructures can be used for phototherapy-mediated breast and lung cancers ablation. The stimuli-responsive and smart kinds of hyaluronic acid-based nanostructures such as pH- and light-responsive can increase selective targeting of breast and lung cancers.

Hyaluronic acid-based prodrug nanomedicines for enhanced tumor targeting and therapy: A review

A potential carrier for anti-tumor targeted delivery-hyaluronic acid nanoparticles

Recent advances in hyaluronic acid-based nanomedicines: Preparation and application in cancer therapy

Hyaluronic Acid-Based Nanocarriers for Anticancer Drug Delivery

Recent Advantage of Hyaluronic Acid for Anti-Cancer Application: a Review of "3S" Transition Approach.

Hyaluronan-modified nanoparticles for tumor-targeting

Hyaluronic Acid-Based Nanomaterials Applied to Cancer: Where Are We Now?

Hyaluronic acid nanocomposites: Progress in derivatization and in preparation methods for anti-tumor applications

Hyaluronic acid and albumin based nanoparticles for drug delivery

Hyaluronic Acid-Conjugated Carbon Nanomaterials for Enhanced Tumour Targeting Ability

Hyaluronic acid and its derivatives in drug delivery and imaging: Recent advances and challenges

A Ph‐responsive Nanoparticle Delivery System Containing Dihydralazine and Doxorubicin‐based Prodrug for Enhancing Antitumor Efficacy

Hyaluronic acid-conjugated methotrexate and 5-fluorouracil for targeted drug delivery

Hyaluronic acid-empowered nanotheranostics in breast and lung cancers therapy

Application of hyaluronic acid-based nanoparticles for cancer combination therapy

Hyaluronic Acid Nanoparticles Based on a Conjugated Oligomer Photosensitizer: Target-Specific Two-Photon Imaging, Redox-Sensitive Drug Delivery, and Synergistic Chemo-Photodynamic Therapy

Hyaluronic acid nanoparticles for targeted oral delivery of doxorubicin: Lymphatic transport and CD44 engagement

Synthesis and biological evaluation of fluorescent hyaluronic acid modified amorphous calcium phosphate drug carriers for tumor-targeting

Redox Responsive Hyaluronic Acid Nanogels for Treating RHAMM (CD168) Over-expressive Cancer, Both Primary and Metastatic Tumors

Hyaluronic Acid-Modified Gold-Polydopamine Complex Nanomedicine for Tumor-Targeting Drug Delivery and Chemo-Photothermal-Therapy Synergistic Therapy

Hyaluronic acid-serum albumin conjugate-based nanoparticles for targeted cancer therapy